eltoprazine has been researched along with Anxiety in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danysz, W; Dekundy, A; Franke, L; Gravius, A; Vanaga, A | 1 |
| Di Scala, G; Hoyer, D; Rigo, M; Rocha, B; Sandner, G | 1 |
2 other study(ies) available for eltoprazine and Anxiety
| Article | Year |
|---|---|
Further pharmacological characterization of eltoprazine: focus on its anxiolytic, anorexic, and adverse‑effect potential.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Appetite Depressants; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Exploratory Behavior; Male; Piperazines; Rats; Rats, Sprague-Dawley | 2017 |
Chronic mianserin or eltoprazine treatment in rats: effects on the elevated plus-maze test and on limbic 5-HT2C receptor levels.
Topics: Acetylcholinesterase; Amygdala; Animals; Anxiety; Autoradiography; Behavior, Animal; Binding Sites; Frozen Sections; Hippocampus; Histocytochemistry; In Situ Hybridization; Injections, Intraperitoneal; Male; Maze Learning; Mianserin; Piperazines; Rats; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; RNA, Messenger; Septal Nuclei; Serotonin Receptor Agonists | 1994 |